Compliance Rate
Compliance Rate
51.23%
Compliant submissions
187
Incompliant submissions
178
Total trials
365
My Organizations' Clinical Trials
Showing 650 of 2400 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/02/18
End: 04/30/20
Due: 04/30/21
Phase: N/A
Priority: Normal
Start: -
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 03/07/14
End: 12/14/16
Due: 12/14/17
Phase: N/A
Priority: Normal
Start: -
End: 09/30/05
Due: 09/30/06
Phase: N/A
Priority: Normal
Start: 11/20/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/13/23
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 09/10/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/19/18
End: 07/17/20
Due: 07/17/21
Phase: N/A
Priority: Normal
Start: 03/16/18
End: 10/22/20
Due: 10/22/21
Phase: N/A
Priority: Normal
Start: 07/26/02
End: 02/07/13
Due: 02/07/14
Phase: N/A
Priority: Normal
Start: 04/23/17
End: 11/25/19
Due: 11/25/20
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 05/18/12
End: 08/12/19
Due: 08/12/20
Phase: N/A
Priority: Normal
Start: 11/04/02
End: 01/29/09
Due: 01/29/10
Phase: N/A
Priority: Normal
Start: 04/30/01
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: -
End: 11/30/05
Due: 11/30/06
Phase: N/A
Priority: Normal
Start: 04/28/16
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 07/31/02
End: 07/31/05
Due: 07/31/06
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 07/31/99
End: 07/31/03
Due: 07/31/04
Phase: N/A
Priority: Normal
Start: 03/12/20
End: 01/01/21
Due: 01/01/22
Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults
Phase: N/A
Priority: Normal
Start: 12/31/03
End: 10/31/05
Due: 10/31/06